BKD Brookdale Senior Living Inc.
Brookdale Senior Living Inc. owns, manages, and operates senior living communities in the United States. It operates in three segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRCs). The Independent Living segment owns or leases communities comprising independent and assisted living units in a single community that are primarily designed for middle to upper income seniors. The Assisted Living and Memory Care segment owns or leases communities consisting of freestanding, multi-story communities and freestanding single-story communities, which offer housing and 24-hour assistance with activities of daily living for the Company's residents. This segment operates memory care communities for residents with Alzheimer's and other dementias. The CCRCs segment owns or leases communities that provides various living arrangements, such as independent and assisted living, memory care, and skilled nursing; and services to accommodate various levels of physical ability and healthcare needs. It manages communities on behalf of others. The company was incorporated in 2005 and is headquartered in Brentwood, Tennessee.…
Industry Peers
Medical Care FacilitiesKey Statistics
About Brookdale Senior Living (NYSE: BKD)
›
Brookdale Senior Living (NYSE: BKD) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 22,440 employees.
The shares were at 8.860 USD on 20 November 2026, down 15.1% over 52 weeks. Its 52-week range is 8.510 USD to 17.09 USD: the price is 48.2% below the high and 4.1% above the low.
Its market capitalisation is 2.12B USD.
Brookdale Senior Living reports an operating margin of 6.2% and revenue down 9.0% year over year.
Its debt exceeds its cash by 5.18B USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 6 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 16.17 USD is 82.5% above the current price. The next earnings report is expected on 17 February 2027.